![Uma Sinha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uma Sinha
Hoofd Techniek/Wetenschap/O&O bij
EIDOS THERAPEUTICS, INC.
Vermogen: 61 200 $ op 30-06-2026
Profiel
Momenteel bekleedt Uma Sinha de functie van Chief Scientific Officer van BridgeBio Pharma, Inc. en Chief Scientific Officer voor Eidos Therapeutics, Inc. (een dochteronderneming van BridgeBio Pharma, Inc.). Dr. Sinha was voorheen Chief Scientific Officer van Global Blood Therapeutics, Inc., Principal bij COR Therapeutics, Inc., Senior Director-Cardiovascular bij Millennium Pharmaceuticals, Inc., Principal bij Genencor International, Inc. en Vice President & Head-Biology bij Portola Pharmaceuticals, Inc. Zij is gepromoveerd aan de Universiteit van Georgia en heeft een bachelorgraad behaald aan het Presidency College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-05-2026 | 30.000 ( 0,02% ) | 61 200 $ | 30-06-2026 |
Actieve functies van Uma Sinha
| Bedrijven | Functie | Begin |
|---|---|---|
| EIDOS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2016 |
| BRIDGEBIO PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2016 |
| PROKIDNEY CORP. | Directeur/Bestuurslid | 01-07-2022 |
Eerdere bekende functies van Uma Sinha
| Bedrijven | Functie | Einde |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2015 |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-12-2012 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Corporate Officer/Principal | 01-01-2002 |
| PROKIDNEY A | Directeur/Bestuurslid | - |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Corporate Officer/Principal | - |
Opleiding van Uma Sinha
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
68
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Presidency College
 Presidency College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Social Capital Suvretta Holdings Corp. III
 Social Capital Suvretta Holdings Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
ProKidney Corp.
 ProKidney Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
